12 disclosed deals worth $6.7B in the displayed window (tracked book: 21 rounds, $8.12B weekly, +1.4% vs prior week). Isomorphic Labs' $5.0B Series C (Greenoaks/Sequoia) accounts for roughly three-quarters of displayed capital; Genesis AI's $500M Series A at $3.5B and Payhawk's $280M Series C at $2.0B follow. Biotech took $5.26B of the tracked week vs AI at just $465M (-84.8% WoW) — a single-deal concentration effect, not necessarily a sector rotation. All figures cover tracked companies only. Most items in this window were announced Nov 17–19; no deals fall within the last 24 hours.
In the last 24 hours: regional startup-ecosystem items dominate — Hub71's international expansion program, an Israel–India deep-tech launchpad, Ireland's 10,000-founders target, Japan partnership coverage, and India–Egypt/Finland cross-border overtures. These are program announcements, not funding events. Nothing in the 24h feed changes the funding tape itself; the most material recent-context item remains Cognition's reported $75B valuation talks, which is a negotiation, not a closed round.
Tracked weekly capital: $8.12B across 21 rounds, +1.4% WoW — flat in aggregate but sharply redistributed. Biotech went from 1 round/$100M to 4 rounds/$5.26B (+5158%, driven almost entirely by Isomorphic). Robotics +133% to $700M; Healthcare ($592M), Financial Software ($530M), Space/Defense ($124M) appear from zero. Offsets: AI -84.8% to $465M, Energy -74.4%, Cybersecurity -74%. Scope is 2,808 tracked companies — a sample, not the whole market.
| Window | Rounds | Disclosed Amounts | Disclosed Capital |
|---|---|---|---|
| Last 24 hours | 0 | 0 | — |
| Last 7 days | 21 | 21 | $8.1B |
| Previous 7 days | 21 | 21 | $8.0B |
Week-over-week disclosed capital: +1.4%. All eligible tracked rounds are included, independently of the 12-company display limit below. Missing amounts are excluded from capital totals, not estimated. Date-only records use midnight UTC; these are rolling windows, not calendar-day totals.
| Sector | 7d Rounds | Prior 7d Rounds | 7d Disclosed Capital | Capital Change |
|---|---|---|---|---|
| Biotech | 4 | 1 | $5.3B | +5158.5% |
| Robotics | 2 | 1 | $700M | +133.3% |
| Healthcare | 3 | 0 | $592M | Not comparable |
| Financial Software | 2 | 0 | $530M | Not comparable |
| AI | 5 | 6 | $465M | -84.8% |
| Energy | 1 | 1 | $128M | -74.4% |
| Cybersecurity | 1 | 2 | $125M | -74.0% |
| Space / Defense | 1 | 0 | $124M | Not comparable |
Payhawk's $2.0B Series C is the week's clearest re-rating: +94.2% vs its $1.03B mark from March 2022 — recovery after a long private-market plateau, not recent appreciation. First-time marks: Genesis AI $3.5B, Variational $1.5B, Science Corporation $3.5B, Model ML $1.5B, Tiberius Aerospace $1.0B, Corma $1.0B, BrightAI $750M. All are reported post-money figures from announcement day; 13 rounds this week lack valuations, and a round price is not a liquid mark.
| Company / Round Date | Reported Post-Money | Prior Post-Money / Date | Mark Change | Evidence |
|---|---|---|---|---|
| BrightAI 2026-11-18 | $750M | Unavailable | Not comparable | Tracked roster; source link unavailable |
| Payhawk 2026-11-18 | $2.0B | $1.0B 2022-03-07 | +94.2% | Tracked roster; source link unavailable |
| Variational 2026-11-18 | $1.5B | Unavailable | Not comparable | Tracked roster; source link unavailable |
| Genesis AI 2026-11-17 | $3.5B | Unavailable | Not comparable | Tracked roster; source link unavailable |
| Model ML 2026-11-17 | $1.5B | Unavailable | Not comparable | Tracked roster; source link unavailable |
| Science Corporation 2026-11-17 | $3.5B | Unavailable | Not comparable | Tracked roster; source link unavailable |
| Tiberius Aerospace 2026-11-17 | $1.0B | Unavailable | Not comparable | Tracked roster; source link unavailable |
| Corma 2026-11-16 | $1.0B | Unavailable | Not comparable | Tracked roster; source link unavailable |
Historical round marks are not replaced with today's company valuation. Mark changes compare disclosed post-money levels, not investor returns; dilution and financing terms may differ. Secondary indications, fund marks and enterprise values in linked reporting are separate evidence, not interchangeable round valuations.
Disclosed round capital in the window. Undisclosed amounts count as zero.
Disclosed rounds in the window · every bar opens the company's live page.
12 disclosed deals worth $6.7B in the displayed window (tracked book: 21 rounds, $8.12B weekly, +1.4% vs prior week). Isomorphic Labs' $5.0B Series C (Greenoaks/Sequoia) accounts for roughly three-quarters of displayed capital; Genesis AI's $500M Series A at $3.5B and Payhawk's $280M Series C at $2.0B follow. Biotech took $5.26B of the tracked week vs AI at just $465M (-84.8% WoW) — a single-deal concentration effect, not necessarily a sector rotation. All figures cover tracked companies only. Most items in this window were announced Nov 17–19; no deals fall within the last 24 hours.
| Date | Company | Round | Amount | Reported Post-Money | Lead | Sector |
|---|---|---|---|---|---|---|
| 2026-11-19 | Boltz | Series A | $110M | — | Bessemer Venture Partners | AI |
| 2026-11-18 | Ansa Biotechnologies | Series C | $72M | — | Blue Water Life Science Advisors | Biotech |
| 2026-11-18 | BrightAI | Growth round (series undisclosed) | $97M | $750M | Smith Point Capital | AI |
| 2026-11-18 | Linq | Series B | $90M | — | Andreessen Horowitz | AI |
| 2026-11-18 | MegaRobo Technologies | Growth round (series undisclosed) | $200M | — | — | Robotics |
| 2026-11-18 | Payhawk | Series C | $280M | $2.0B | Growth Equity at Goldman Sachs Alternatives | Financial Software |
| 2026-11-18 | Variational | Series B | $110M | $1.5B | Bain Capital Crypto | Fintech |
| 2026-11-18 | VitriVax | Series C | $87M | — | F-Prime / NEA / RA Capital Management / Sanofi Ventures | Biotech |
| 2026-11-17 | General Flash | Seed + Series A | $128M | — | Lux Capital / Overmatch Ventures | Energy |
| 2026-11-17 | Genesis AI | Series A | $500M | $3.5B | Khosla Ventures / Premji Invest / Eclipse | Robotics |
| 2026-11-17 | Isomorphic Labs | Series C | $5.0B | — | Greenoaks / Sequoia Capital | Biotech |
| 2026-11-17 | LanceDB | Series B | $58M | — | Bessemer Venture Partners / Innovation Endeavors | AI |
Where the window's activity sits on the funding ladder: deal count (solid) against disclosed capital (faded) per stage, with the companies behind each cluster. Stages come from the reported round labels; undisclosed amounts count as zero capital.
Bessemer led two of the 12 displayed deals (Boltz $110M Series A; LanceDB $58M Series B with Innovation Endeavors) — its only two appearances on this tape, so treat as activity, not a thesis statement. AI rounds on the board are mid-sized ($58M–$110M) despite the sector's outsized headline presence; the big robotics money (Genesis AI, MegaRobo) came outside pure AI labels. Coverage caveat: 13 of this week's tracked rounds lack valuation data, and lead check sizes are not disclosed — listed totals are round sizes, not individual checks.
| Lead Investor | Displayed Deals | Associated Round Sizes |
|---|---|---|
| Greenoaks / Sequoia Capital | 1 | $5.0B |
| Khosla Ventures / Premji Invest / Eclipse | 1 | $500M |
| Growth Equity at Goldman Sachs Alternatives | 1 | $280M |
| Lux Capital / Overmatch Ventures | 1 | $128M |
| Bessemer Venture Partners | 1 | $110M |
| Bain Capital Crypto | 1 | $110M |
| Smith Point Capital | 1 | $97M |
| Andreessen Horowitz | 1 | $90M |
Total sizes of associated rounds, not the lead investor's check sizes. Investor types are not inferred from their names.
BILL agreed to a $6B take-private by TPG and Corpay (announced Nov 20, recent context — closing not confirmed). JPMorgan is reportedly weighing sale of $2B of software buyout debt at ~80 cents on the dollar, signaling financing pressure in LBO books (last 24h). EQT to acquire Australian auction platform Pickles from Apax — a secondary-style GP-to-GP handoff. Africa PE weekly roundup and UK advisory marketing content round out the feed; thin substantive deal flow in this window.
The Economist reports identity questions at Saudi Arabia's ~$1trn wealth fund (last 24h) — a strategy story worth monitoring for deployment cadence. FT flags fresh LP concerns over 'sell-to-yourself' continuation deals (last 24h). New vehicles: Oister Global's $64.5M India deeptech growth fund; JSW Ventures' $47M first close on Fund III; First Circle's $26M Africa fintech fund. Fund sizes are commitments, not deployable startup capital this week.
Reported, not confirmed: Amazon near a $7.5B deal for Israeli AI startup Decart (Chosun Ilbo, BigGo, last 24h); Palo Alto Networks in talks for AI cyber startup Terra at possibly >$500M (CTech, last 24h); CrowdStrike in talks over Zscaler (Tech in Asia, recent context). None of these have closing confirmation — report as negotiation-stage. A second-hand item claims an $8.2B founder exit under three years from launch; the underlying target is not identified in the evidence, so we treat it as unverified color.
Funding headlines from outside the tracked book — sourced links, not QL data.
The largest recent private rounds ($100M+) across the tracked book — 2376 ranked. Full board: quantlogix.ai/mega-rounds.
Biggest overnight changes in the graded company score — scores only move when disclosed data moves, and every repricing grades the score that was standing.
| Company | Score | Δ |
|---|---|---|
| Atlas Atomics | 57 → 60 | +3 |
Display-only private-markets tape from the tracked roster — formations, priced fundraises, valuation marks, and U.S. VC lead activity. No inferred amounts; empty sections stay empty.
Window: 2026-11-21 · sources: private-companies.json, investors.json
| Name | Round / detail | Amount / mark | Date |
|---|---|---|---|
| Mirendil | formation | — | 2026-11-21 |
| Genesis AI | formation | — | 2026-11-21 |
| Torus | formation | — | 2026-11-21 |
| Path Robotics | formation | — | 2026-11-21 |
| Sand.ai | formation | — | 2026-11-21 |
| MegaRobo Technologies | formation | — | 2026-11-21 |
| Blue J | formation | — | 2026-11-21 |
| Noeri | formation | — | 2026-11-21 |
| Boltz | formation | — | 2026-11-21 |
| Linq | formation | — | 2026-11-21 |
| Tutor Intelligence | formation | — | 2026-11-21 |
| 42AI | formation | — | 2026-11-21 |
No rows in the report window.
No rows in the report window.
No rows in the report window.
Weekend — payload available; weekday auto-DM is Mon–Fri 8:00 AM PT.
The Silicon Valley Private Market Daily — the 8pm PT desk close: qualified raises, roster re-rates and sector velocity from the QL private-market pipeline.
The private market is currently experiencing significant uncertainty following the high-profile departure of Jensen Huang, whose active backing was a cornerstone of AI startup valuations. This leadership gap is driving expectations for smaller funding checks and lower valuations. Meanwhile, market concentration remains high in AI infrastructure and enterprise agents, with mega-deals like Sierra's $30 billion valuation talk contrasting with a broader cooling environment for speculative tech.
🗂️ Dataset updated: added 1 company to the QuantLogix private-companies list — Unsiloed AI — 2,780 → 2,781. Append-only.
100 tracked names flagged for markdown risk — 126 scored nightly, 2573 left unscored (no comp bridge). Down rounds are recorded in the open ledger — receipts only work in public. Live boards: markdown-watch · down-round-ledger.
| # | Company | Sector | Risk Score | Band | Vs Comps | Last Mark | Last Round |
|---|---|---|---|---|---|---|---|
| 1 | Linktree | SaaS | 86 | High | +947% | $1.3B | 56 mo ago |
| 2 | Replit | Data / Infra | 86 | High | +553% | $9.0B | 43 mo ago |
| 3 | Kajabi | SaaS | 86 | High | +201% | $2.0B | 67 mo ago |
| 4 | Xendit | Financial Services | 80 | High | +1843% | $2.7B | 54 mo ago |
| 5 | Forter | Fintech | 80 | High | +949% | $3.0B | 66 mo ago |
| 6 | Greenlight | Fintech | 80 | High | +602% | $2.3B | 68 mo ago |
| 7 | Varo | Fintech | 80 | High | +437% | $2.5B | 62 mo ago |
| 8 | Betterment | Fintech | 80 | High | +426% | $1.1B | 44 mo ago |
Nightly score: comp-bridge premium (45%) · round staleness (30%) · IPO-readiness drag (15%) · funding deceleration (10%). Companies without a computable public-comp bridge stay unscored — never guessed.
98 markdowns detected all-time · 22 flagged beforehand · 76 missed · hit rate 22.4%
| Company | Detected | Event | Mark | Called? |
|---|---|---|---|---|
| Vinted | 2026-11-16 | Mark cut −5.4% | $9.3B → $8.8B | ✗ Missed |
| Suno | 2026-11-16 | Mark cut −18.4% | $2.5B → $2.0B | ✗ Missed |
| Cyera | 2026-11-16 | Mark cut −25.0% | $12B → $9.0B | ✗ Missed |
| OpenAI | 2026-11-09 | Mark cut −31.8% | $1250B → $852B | ✓ Flagged #79 · Moderate |
| Kraken | 2026-11-09 | Mark cut −48.3% | $21B → $11B | ✓ Flagged #84 · Moderate |
| TRM Labs | 2026-11-09 | Mark cut −50.0% | $2.0B → $1.0B | ✗ Missed |
| Incode | 2026-11-09 | Mark cut −64.0% | $3.0B → $1.1B | ✗ Missed |
| Current | 2026-11-09 | Mark cut −88.0% | $13B → $1.5B | ✗ Missed |
Down-round & valuation headlines scraped at publication from Google News, Hacker News, CNBC, Yahoo Finance and the wider tech press.
Isomorphic's $5.0B round alone put biotech at $5.26B of $8.12B weekly tracked capital, up from $100M the prior week. Read it as one mega-deal skewing the sample, not a durable shift — but it does confirm deep-pocketed appetite for later-stage, science-heavy risk. Founders raising in AI should note their sector took just $465M on this book, down 85% WoW; don't anchor to last month's AI-heavy tape when sizing expectations.
Payhawk moved from $1.03B (March 2022) to $2.0B post-money in its Goldman-led Series C — one of the few week-over-week valuation deltas with a real prior mark. It took nearly four years to double, which is a realistic benchmark against the $1.5B Series B marks appearing around Model ML and Variational with no prior comparison. Ground your expectations in the Payhawk cadence, not the headline unicorns.
The ledger shows recent cuts at Suno (-18.4%) and Cyera (-25%), 100 names on watch, and external evidence of Firebolt exiting via MongoDB below its $1.4B peak, SmartNews IPO-ing after an 80% cut, and 2021 crypto unicorns marked down 50–70% in secondaries. If your round math assumes peak-cycle comps, pressure-test it: secondary buyers and acquirers are clearing well below last private marks.
Watch three threads: whether Isomorphic's $5B closes the biotech mega-round spigot beyond one deal; whether Cognition's reported $75B talks and Amazon–Decart convert into confirmed transactions; and whether the JPMorgan software-debt discount spreads into sponsor exit math. AI's quiet week on tracked rounds cuts against narrative; treat the flat +1.4% WoW total as the honest baseline.